This demonstrated that PRMT5 knockdown induced an antitumor response through regulation of CXCL10 expression and suggested that PRMT5 inhibitors could serve as a promising therapeutic strategy for cervical cancer treatment. Here, CXCL10 is linked to cervical carcinoma.